Eli Lilly and Co. on Friday said it has warned doctors that its schizophrenia treatment Zyprexa, its best-selling drug, significantly raises the risk of death and stroke in elderly patients suffering from dementia.
Eli Lilly and Co. on Friday said it has warned doctors that its schizophrenia treatment Zyprexa, its best-selling drug, significantly raises the risk of death and stroke in elderly patients suffering from dementia.